The residual cancer burden index was developed as a method to quantify residual disease ranging from pathological complete response to extensive residual disease. The aim of this study was to evaluate ...

For that, we use a different measure: the concordance correlation coefficient, introduced by Lin in 1989. This metric focuses specifically on how well the data align with a 45-degree line. What we've ...